(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.)
Pelago, which provides digital substance use treatment for substances like opioids and tobacco, said it is expanding to cover more substances as employers seek out a digital solution to lower costs.
The startup on Thursday said it raised $58 million in Series C funding, bringing its total to $151 million. It sends patients remote monitoring devices such as breathalyzers, provides virtual access to physicians and coaches, and prescribes medication if needed.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.